Search results for "Spinal"

showing 10 items of 906 documents

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

2004

The cytokine erythropoietin (Epo) is tissue-protective in preclinical models of ischemic, traumatic, toxic, and inflammatory injuries. We have recently characterized Epo derivatives that do not bind to the Epo receptor (EpoR) yet are tissue-protective. For example, carbamylated Epo (CEpo) does not stimulate erythropoiesis, yet it prevents tissue injury in a wide variety ofin vivoandin vitromodels. These observations suggest that another receptor is responsible for the tissue-protective actions of Epo. Notably, prior investigation suggests that EpoR physically interacts with the common β receptor (βcR), the signal-transducing subunit shared by the granulocyte-macrophage colony stimulating fa…

Time FactorsBiologyMotor ActivityHeteroreceptorNeuroprotectionCell LineMicemedicineReceptors ErythropoietinAnimalsVentricular Functionerythropoietin receptor; common beta receptor; tissue injury; CytokinesReceptorErythropoietinAortaCells CulturedSpinal Cord InjuriesMice KnockoutMultidisciplinaryCell MembraneBiological SciencesErythropoietin Erythropoietin receptor neuroprotectionErythropoietin receptorCell biologyMice Inbred C57BLProtein SubunitsErythrocyte maturationErythropoietinKnockout mouseImmunologyErythropoiesismedicine.drug
researchProduct

Does granulocyte-colony stimulating factor stimulate peripheral nerve regeneration? An experimental study on traumatic lesion of the sciatic nerve in…

2021

Aim of the study. To analyse the therapeutic potential of granulocyte-colony stimulating factor (G-CSF) treatment using a rat model of traumatic sciatic nerve lesion. Clinical rationale for the study. G-CSF has proven strong neurotrophic properties in various models of ischaemic and traumatic brain injury. Fewer studies exist regarding the influence of G-CSF on posttraumatic peripheral nerve regeneration. Currently, the possibilities of pharmacological prevention or treatment of mechanical nerve injury are limited, and there is an urgent need to find new treatment strategies applicable in clinical situations. Material and methods . A controlled traumatic right sciatic nerve lesion was set u…

Traumatic brain injuryLesionGranulocyte Colony-Stimulating FactormedicineAnimalsHumansbiologybusiness.industrySciatic nerve injuryNerve injurymedicine.diseaseSpinal cordSciatic NerveGranulocyte colony-stimulating factorNerve RegenerationRatsDisease Models Animalmedicine.anatomical_structureAnesthesiabiology.proteinSurgeryNeurology (clinical)Sciatic nervemedicine.symptomSciatic NeuropathybusinessNeurotrophinGranulocytesNeurologia i neurochirurgia polska
researchProduct

Use of Machine Learning and Artificial Intelligence to Drive Personalized Medicine Approaches for Spine Care

2020

Personalized medicine is a new paradigm of healthcare in which interventions are based on individual patient characteristics rather than on “one-size-fits-all” guidelines. As epidemiological datasets continue to burgeon in size and complexity, powerful methods such as statistical machine learning and artificial intelligence (AI) become necessary to interpret and develop prognostic models from underlying data. Through such analysis, machine learning can be used to facilitate personalized medicine via its precise predictions. Additionally, other AI tools, such as natural language processing and computer vision, can play an instrumental part in personalizing the care provided to patients with …

Traumatic spinal cord injuryPrognosiPsychological interventionPatient characteristicsDiseaseSpinal cord injuryMachine learningcomputer.software_genreSpinal DiseaseMachine Learning03 medical and health sciences0302 clinical medicineArtificial IntelligenceHealth careFunctional StatuMedicineHumansSpine carePrecision MedicineDegenerative cervical myelopathyPrognostic modelsSpinal Cord InjuriesNatural Language ProcessingSpinal Cord Injuriebusiness.industryPrognosisPersonalized medicineFunctional Status030220 oncology & carcinogenesisSurgeryFunctional statusSpinal DiseasesNeurology (clinical)Personalized medicineArtificial intelligenceSpondylosisbusinesscomputerSpinal Cord Compression030217 neurology & neurosurgeryHuman
researchProduct

Functional Anatomy of the Spinal Trigeminal Nucleus

1993

The trigeminal nerve (nV) conveys general somatic afferent exteroceptive input from the skin of the face and the frontal parts of the head, the mucous membranes of the oral cavity, tongue and nose, the tooth pulp, eye and meninges via the trigeminal (Gasserian) ganglion to the nuclei of termination [28]. Somatosensory input reaches the principal sensory nucleus of the nV and the spinal trigeminal nucleus of the nV (STN). Proprioceptive input from masticatory muscles innervated by trigeminal motor efferents is transferred to the nV mesencephalic nucleus.

Trigeminal nerveProprioceptionbusiness.industrySuperior colliculusSpinal trigeminal nucleusAnatomyInferior alveolar nerveSomatosensory systemmedicine.diseaseGanglionmedicine.anatomical_structureTrigeminal neuralgiamedicinebusiness
researchProduct

Type II Odontoid Fracture: a case series highlighting the treatment strategies

2019

Background: A type II odontoid fracture, if unstable, can cause spinal cord damage. In this case, it is essential to choose the correct treatment—but the issues of what the correct treatment is and which of the different surgical options is best are quite controversial. In this paper we present strategies for treatment of type II odontoid fracture. Materials and Methods: Thirty consecutive cases of type II odontoid fracture were treated at the Division of Neurosurgery at Villa Sofia Hospital in Palermo (23 cases) and at the Neurosurgical Clinic, University Hospital of Palermo (seven cases), from January 2011 to August 2016. Four patients were treated with external immobilization. Twenty-six…

Type II odontoid fracturemedicine.medical_specialtyC1–C2 instabilitySettore MED/27 - Neurochirurgiabusiness.industryBone ScrewExternal FixatorSpinal cord030218 nuclear medicine & medical imagingSurgeryFracture Fixation InternalOdontoid Proce03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureC1–C2 articular screwFracture FixationmedicineSpinal FracturesTreatment strategybusinessOdontoid screw030217 neurology & neurosurgeryHumanOdontoid fracture
researchProduct

Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.

2001

The level of 14-3-3gamma protein was determined in the cerebrospinal fluid (CSF) from patients with Creutzfeldt-Jakob disease (CJD) and non-CJD patients applying a new and fast microplate assay (14-3-3 protein capture assay), based on the binding to a peptide comprising a phosphorylated recognition motif of 14-3-3 protein. The levels of the gamma-isoform of 14-3-3 protein in CSF samples from CJD patients (n=41) were significantly higher than those observed in patients with non-CJD dementias (n=36) suggesting that this capture assay is a reliable method in the diagnosis of CJD. Since this assay allows the direct measurement of 14-3-3 protein in the CSF without prior concentration it is an ea…

Tyrosine 3-MonooxygenaseImmunoblottingPeptideEnzyme-Linked Immunosorbent AssayPlasma protein bindingBiologySensitivity and SpecificityCreutzfeldt-Jakob SyndromeCerebrospinal fluidmental disordersHumansIn patientPhosphorylation14-3-3 proteinchemistry.chemical_classificationGeneral NeuroscienceCreutzfeldt-Jakob SyndromeVirologyMolecular biologynervous system diseasesHighly sensitivechemistry14-3-3 ProteinsChemistry ClinicalPhosphorylationProtein BindingNeuroscience letters
researchProduct

A Spinal Muscular Atrophy Reporter System for in vivo Drug Discovery in Drosophila melanogaster

2018

Fondo La Atrofia Muscular Espinal es un desorden neuromuscular raro y fatal causado por la pérdida o reducción en los niveles de proteína de la Neurona Motor de Supervivencia (SMN). Los individuos afectados tienen el gen SMN1 mutado y la copia SMN2 específica de humanos no afectada, que se traduce solo parcialmente en una proteína SMN funcional. La activación farmacológica de la inclusión del exón 7 de SMN2 por moléculas pequeñas o oligonucleótidos antisentido modificados es un enfoque prometedor para tratar la SMA. Obtener nuevos compuestos potencialmente terapéuticos para los ensayos clínicos es un proceso largo y costoso. El enfoque de reposicionamiento de medicamentos puede reducir el t…

UNESCO::CIENCIAS DE LA VIDAdrosophila melanogasternervous system diseasesdrug discoveryspinal muscular atrophy
researchProduct

European evidence-based recommendations for clinical assessment of upper limb in neurorehabilitation (CAULIN): data synthesis from systematic reviews…

2021

Abstract Background Technology-supported rehabilitation can help alleviate the increasing need for cost-effective rehabilitation of neurological conditions, but use in clinical practice remains limited. Agreement on a core set of reliable, valid and accessible outcome measures to assess rehabilitation outcomes is needed to generate strong evidence about effectiveness of rehabilitation approaches, including technologies. This paper collates and synthesizes a core set from multiple sources; combining existing evidence, clinical practice guidelines and expert consensus into European recommendations for Clinical Assessment of Upper Limb In Neurorehabilitation (CAULIN). Methods Data from systema…

UT-Gold-Dassessmentmedicine.medical_treatmentDelphi methodmultiple sclerosisOutcome measuresaivohalvausOutcome measureTraumatic brain injuryInternational Classification of Functioning Disability and HealthMS-tautiupper extremityMedicineUpper limblääkinnällinen kuntoutusRehabilitationtraumatic brain injuryRehabilitationStroke RehabilitationstrokeTest (assessment)StrokeSystematic reviewRC321-571medicine.medical_specialtyEvidence-based practiceConsensusUpper extremity616.8: Neurologie und Krankheiten des NervensystemsNeurosciences. Biological psychiatry. NeuropsychiatryHealth Informaticsupper limbkädetSpinal cord injuryAssessmenthermoston tauditkäsivarretaivovammatrehabilitationMultiple sclerosisoutcome measuresPhysical medicine and rehabilitationOutcome measures; Stroke; Traumatic brain injury; Spinal cord injury;HumansUpper limb; Upper extremity; Assessment; Rehabilitation; Therapy;Set (psychology)Neurorehabilitationselkäydinvammattherapybusiness.industryResearchReproducibility of ResultsRecovery of FunctionHandspinal cord injuryTherapybusiness
researchProduct

Effects of deep cervical flexor training on pressure pain thresholds over myofascial trigger points in patients with chronic neck pain.

2012

The purpose of this study was to assess the effects of a low-load training program for the deep cervical flexors (DCFs) on pain, disability, and pressure pain threshold (PPT) over cervical myofascial trigger points (MTrPs) in patients with chronic neck pain.Thirty patients with chronic idiopathic neck pain participated in a 6-week program of specific training for the DCF, which consisted of active craniocervical flexion performed twice per day (10-20 minutes) for the duration of the trial. Perceived pain and disability (Neck Disability Index, 0-50) and PPT over MTrPs of the upper trapezius, levator scapulae, and splenius capitis muscles were measured at the beginning and end of the training…

Upper trapeziusAdultMaleManipulation Spinalmedicine.medical_specialtyPressure painAdolescentFacial NeuralgiaSeverity of Illness IndexCohort StudiesChronic neck painYoung AdultPhysical medicine and rehabilitationNeck MusclesMedicineHumansIn patientProspective StudiesTraining periodPain MeasurementMassageNeck painAnalysis of VarianceReferred painNeck Painbusiness.industryTrigger PointsMiddle AgedTreatment OutcomeSensory ThresholdsPhysical therapyFemaleChiropracticsmedicine.symptomChronic PainTraining programbusinessFollow-Up StudiesJournal of manipulative and physiological therapeutics
researchProduct

Nusinersen in adult patients with 5q spinal muscular atrophy: a multicenter observational cohorts’ study

2021

ABSTRACTObjectiveTo assess safety and efficacy of nusinersen in adult 5q spinal muscular atrophy (SMA) patients.MethodsPatients older than 15 years and followed at least for 6 months with one motor scale (Hammersmith Functional Motor Scale Expanded, HFMSE; Revised Upper Limb module, RULM) in five referral centers were included. Clinical and patients’ global impression of change (CGI-C and PGI-C) were recorded in treated patients at the last visit. Functional scales (Egen Klassification, EK2; Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, ALSFRS-R) and the percent-predicted forced vital capacity were collected when available.ResultsSeventy-nine SMA patients (39 treated with n…

Vital capacitymedicine.medical_specialtybusiness.industrySpinal muscular atrophySMA*medicine.diseasemedicine.anatomical_structureRating scaleInternal medicinemedicineUpper limbNusinersenAmyotrophic lateral sclerosisbusinessAdverse effect
researchProduct